republican

immunotherapy

SELLAS Life Sciences Group Inc

buying

$SLS  I wont be buying anymore shares until the CEO can show is company is worth at least 150m marketcap 
 
Look at the 3 year chart be warned the CEO is a scam artist and a liar

You are better off hoarding cash vs buying into a company where the staff sells free shares and does not deserve pay raises during a economic crisis/recession.

$SLS  No one should be buying in at these prices though.

$SLS SERIOUSLY STOP FUCKING RUNNING ALL THE BUYING OTC DARK POOL!!!

This MM is refusing to honor order flow, they are refusing to move the price higher when buying comes in, they are dictating price direction and that&#39;s not their fucking job.

HOW THE FUCK DID THEY JUST FILL 24k BUYING VOLUME AND NOT A SINGLE $.01 MOVE!!!!

but buying inflow and a 5K buy order and yet POS MM will not let it fucking go!! !

application

Gfh009 is a joke and will ruin this stock until 3d meds sees fda approval for aml gps.

16/16 
In all 3 Options GPs gets FDA approval due to QOL, venclexta, onureg, oralAz - all Cr1 salvage agents are highly toxic.

This concerns me, we get the dreaded not statistically relevant ruling from the FDA.

- OUTRIGHT LIE saying THEN 52 weeks - PURE BS 
- OUTRIGHT LIE saying THEN patients need to Die 
Co is now on RECord Reiterating 80 Events, patient deaths in Q1Q2 
That is the fda green light moment.

announcement

You fucked up and shorted NCI non dilutive funding announcement and patients living longer news.

$SLS they supposedly hired a lawyer fill time and this was never announced .

The shorts feeling the pain on their announcement.

$SLS For those predicting some big announcement from Sellas on the 14th at the Regal symposium, you are going to be terribly disappointed.

investor

What a freaking smack in the face to investors.

Angelos has intentionally screwed the long term investor.

$SLS I find it arrogant that SLS would even investors were concerned about their SIVB exposure.

but after doing an offering and the way the market is, the company should be giving some communication,  otherwise you are showing you really don&#39;t care about long term  investors,  personally  I&#39;m not impressed with the way it&#39;s been handled.

$SLS This is a JOKE and the JOKE is on the real investors ☹️

$SLS SLS investors have two problems now.

If you’re an experienced investor and you buy this scam, you deserve to lose you your investment.

$SLS No one should buy  in to this unless you are new investor.

They need to communicate and support their investors and shareholders.

Scary that I bought 2 years ago 9000 shares $6.50 average price to see this today just seems like he doesn’t care at all for investors why would he?

Nancy Pelosi the Hag was fired and now this is just the start of a bullish market with the house being led by Republicans.

$SLS markets are bullish because Nancy pelosi was fired and we now have a republican leading the house.

$SLS $XBI  
when republicans take control of the house  and all votes are finalized , we are going to see another bullish run like we did today 
 
Election Day | 2022 Statewide General Election 
Tue, Nov 8 2022, 6:30am - 7:30pm

I have concluded SLS are developing the best in a class of immunotherapy drug.

- The First Safe Immunotherapy, that Right now, We Know Extends Overall Survival 3 Fold longer than patients on Best Available Therapies.

2,500% to 5,000% Upside in this ahead of the Fda Green light for Gps, as the first immunotherapy to treat 20,000 AML remission patients.

20,000 AML patients  
GPS a safe immunotherapy that cures and extends survival duration.

$SLS https://www.science.org/doi/10.1126/sciadv.abe3348 
 
Sellase are developing one of the best immunotherapy drug!!!!

A safe non toxic effective WTI immunotherapy that will ultimately treat upwards of 20,000 AML patients in remission each year .

$SLS Simple setup: BUY and Hold as many as you can… price will only be higher, much higher when Gps gets the FDA Green light, a safe immunotherapy that will prevent relapse for 10,000+ AML remission pa each year.

Do the math: a Safe  
Immunotherapy that will cure and prevent relapse for 10,000 AML patients in remission.

Literally the best set up in the history of Baby bios about to Grow Up. https://www.chinamoneynetwork.com/2020/10/10/immunotherapy-company-3d-medcines-raises-funds-after-spin-off

$SLS True North valuation is literally a ticket to the Moon - DD  
Gps is safe durable Aml cancer killer, an immunotherapy that will prevent relapse and cure 40,000 AML patients.

patient

It reported positive outcomes in pleural mesothelioma patients, including:
Improved survival: Study patients lived around 11 months.

* Best Available Therapy offers 6-8 months of Overall Survival  
* All pooled Regal patients, BAT and Gps combined, is 16 months.

* Best Available Therapy offers 6-8 months of Overall Survival 
* All pooled Regal patients, BAT and Gps combined, is 16 months.

Now phase 3 trial is showing similar results to date where patients are living longer after Galinpepimut-S up to 1.5 year longer is a breakthrough for AML patients.

- Best available treatment 6-8 months of os.

- Cured GPS patients, continue to elongate the OS curve in Gps favor every day that goes by.

$SLS In addition to GPs FDA approval for AML secondary Remission patients - Gps + Keytruda/Checkpoint Inhibition is also best in class for Ovarian cancer patients.

$SLS NCT update, nice…
They target 140 patients in 110 investigational sites.

news

$SLS With news on its way, the confidence built in the science, fear factor is gone.

$SLS No breaking news here regarding Sellas, and its well above my understanding,

$SLS good news, at the current rate and the ridiculous prices, in about a month you can buy this company for free.

My guess is that they generated ~3m revenue through the EAP, which would be really great news.

This is a rare opportunity that you know the news is grossly good(it convinced in investor(s)) and still have the chance to load and make 50 to 100% in .month or so.

plenty of upside if there is positive news.

$SLS they picked a great day for this news. lol

So much for this offering being good news.

Positive trial data/results supported with bullish news and sentiment! 4.

trial

PROC data are excellent compared to any combo trials.

But yesterdays paper also has me considering, if there isn&#39;t a deal with $mrk or $BMY or some other CPI BP  
--- That data is Best In Class - best in clinic, best in trial too.

The nation’s best means the O&#39;Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.

Gps is doing what it has done in every single trial and its the reason Patients are living 3 fold longer than patients on best available treatments.

Treatment with GFH009 resulted in 90 to 100 percent cancer inhibition at dose levels equivalent to those already demonstrated to be safe in patients in the ongoing Phase 1 trial with no viable cancer cells at the highest dose levels.

Bristol-Myers Squibb Co.

rating

update

At the last update, Gps Opdivo median Os at 10.4 months- safety issues typical of a $mrna vaccine.

vaccine

manipulation

And our POS MM really wants to keep holding the price at $1.50s and this absolutely fucking ridiculous market cap because they are criminally manipulating the price.

SLS share price is massively manipulated and undervalued - take a look at all the short scumbags begging for sellers.

$XBI Thinly traded, manipulated, undervalued Equity.

$SLS Massively undervalued manipulated Equity  
1.

crash

$SPY $JNJ $PFE $BMY $GILD  these stocks are alll crashing

COMPLETE AND TOTAL ECONOMIC COLLAPSE IS OCCURING.

$BMY COMPLETE AND TOTAL ECONOMIC COLLAPSE IS OCCURING PEOPLE!!!!!

$SLS 
Keytruda  + $MRK = money = extend lives = Superb Cancer drug for immunotherapy.

product

I love the partnerships with big companies… seems to give a good stamp of approval with the products they offer.

$BMY is a great company with great products that unfortunately can’t be afforded by most and will be pressured into slim margins by the Biden administration as we enter a recession.

“Our strong results reflect growth of our in-line and new product portfolios,” said Giovanni Caforio, M.D., board chair and chief executive officer, Bristol Myers Squibb.

3 other approved products, all growing revenue.

3 other approved products, all steady and growing revenue.

This share price is a steal with those great Levo results this morning, and their other 3 approved and growing products.

approval

$LLY $BMY both keep rising with upcoming Approvals on the table.

revenue

Small biotech, 3 drugs, each growing revenue, stable base. 2.

One drug, Recorlev, just rolling out, best in class drug for advanced Cushings being received exceptionally well by doctors and likely thousands of patients will switch at an annual Rx of $250k-350k, will provide hundreds of millions of new revenue.

Top Stocks matching your search for "immunotherapy republican"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Jan, 17, 2023

Jan, 17, 2023

BMY

Bristol-Myers Squibb Co.

-8.70%

$73.65 - $67.24

Jan, 17, 2023

Divihomes is Now Live

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Jan, 17, 2023

Jan, 17, 2023

Nov, 8, 2022

BMY

Bristol-Myers Squibb Co.

-8.70%

$73.65 - $67.24

Jan, 17, 2023